Jeff E. Knight
Chief Development & Operating OfficerMr. Jeff E. Knight, M.P.H., is Chief Development & Operating Officer of ALX Oncology Holdings Inc. from April 13, 2026. Mr. Knight was Chief Operating Officer at Crinetics Pharmaceuticals, Inc. since September 2021 until April 10, 2026 and served as its Chief Development Officer since January 2, 2026 until April 10, 2026. He was Senior Vice President of Portfolio Management & Corporate Operations at Poseida Therapeutics, Inc. since 2021 and served as Senior Vice President of Global Operations since February 2020 until 2021 and was the Vice President, Global Operations since 2019 until February 2020. He was the Vice President of Program Management and Clinical Operations at Onyx Pharmaceuticals, Inc. From March 2017 until October 2018, he was Vice President, Development Operations and Project and Portfolio Management at Halozyme Therapeutics, Inc. From July 2015 until March 2017, he served as Executive Director, Global Development Operations at Amgen. He joined Onyx in 2012 as Senior Director of Clinical Development, Head of Development Strategy and Operations and Head of Medical Writing. Before coming to Onyx, he held several leadership roles of increasing responsibility in Clinical Operations, Clinical Regulatory Affairs and Project Management at Genentech, Inc. He held positions in Clinical Operations and Program Management at PRA International, Hoechst Marion Roussel, Inc (now Sanofi) and the University of Oklahoma Health Sciences Center. He also worked as a critical care nurse at the University of Kansas Hospital. He holds a master’s of public health degree in Biostatistics and Epidemiology from the University of Oklahoma Health Sciences Center. He also earned a B.S. in Nursing with honors from the University of Kansas Medical Center and a B.A. in Psychology from the University of Oklahoma.
Positions
- Company NameALX Oncology Holdings Inc.Stock CodeALXOPositionChief Development & Operating OfficerColleagues
- JWJason W. LettmannCEO & Director
- SGScott GarlandIndependent Chairman
- HSHarish ShantharamChief Financial Officer
- SWShelly WongSenior VP of Finance & Chief Accounting Officer
- BJBarbara J. KlenckeChief Medical Officer
- RHRekha HemrajaniIndependent Director
- KTKeith T. FlahertyChair of the Scientific Advisory Board
- CHChris H. TakimotoIndependent Director
